To all the long holders!
Please do not look at short interest even though it helps during so called squeezer time. What you should look at :cash available, existing programs and the most important the preliminary data. AVEO has plenty of cash,great programs and the HELPING DRUG TIVO along with others in their pipeline.
Aveo has more than 160 mln.,not 60 mln .of available cash,meaning that net cash per share is around $3.25!!! On top of that they AVEO has six other programs in full development. Aveo has no problem with cash even if they have to correct medic.trial. On top of that they have big pocket partner ASTELLA.
Of course if you want to short the stock you want to create the panic..
We will see AVEO crossing $10 and $20 and $30 as their TIVO drug works. It beated seven other drugs in this category., It just a matter of time how fast aveo can fit it in FDA format of approval. Less
Sentiment: Strong Buy
In two years we will see $30 plus....Watch it
This is my last publication.
3-day rule, people that want out, should be out, it might be time for a bounce unless management says, or does something not friendly to shareholder value. THey apparently had no plan B in advance, which is typical of biotech, so they may need a few days to pick the new path, 1) sell 2) renegotiate partner deal and downsize or 3) dilute and cut costs. They are going to have to make severe cuts, so they might as well get started with that ASAP to conserve cash.
greater than 100% flip in o/s shares the past week. Lots of holders sub-$3, will be very difficult for a meaningful appreciation as many shares are probably held by retail now. Will likely touch the $2.25 low today...question is whether it will hold.
agree ...to a certain point...however....many daytraders were in and out after circuit breaker issue on thrusday....aveo from 2.15....to near $3..........i believe most retail is out ....big boys are buying on cheap.
shorts getting pennies now.......hold
wow a bio tech within the boston area.........with japanese company backing....im in